A novel adipose tissue derived bone graft, tentatively named NVDX3, has performed well in its initial test, a single-arm, open-label first-in-human proof-of-concept study in adults with distal radius fractures.
NVDX3 is a three-dimensional (3D) osteogenic graft derived from autologous adipose derived mesenchymal stem cells (ASCs) combined with hydroxyapatite/beta-tricalcium phosphate (HA/TCP) particles.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
